CD86 and neoplasm: Furthermore, we proved the functional importance of co-stimulatory molecules by showing that co-treatment of hRT/lena-treated mice with antibodies blocking CD70, CD83, and CD86 worsened primary and, more prominently, secondary (abscopal) tumor control and diminished overall survival of the mice.